-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Fulgent Genetics, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2014 to 2024.
- Fulgent Genetics, Inc. Income Tax Expense (Benefit) for the quarter ending December 31, 2024 was -$1.85M, a 83% increase year-over-year.
- Fulgent Genetics, Inc. Income Tax Expense (Benefit) for the twelve months ending December 31, 2024 was -$8.14M, a 805% decline year-over-year.
- Fulgent Genetics, Inc. annual Income Tax Expense (Benefit) for 2024 was -$8.14M, a 805% decline from 2023.
- Fulgent Genetics, Inc. annual Income Tax Expense (Benefit) for 2023 was $1.15M, a 97.3% decline from 2022.
- Fulgent Genetics, Inc. annual Income Tax Expense (Benefit) for 2022 was $42.1M, a 75.9% decline from 2021.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)